Bristol-Myers Squibb's Oncology Revenues Will Likely Be Around $11 Billion By Next Year - Forbes

Bristol-Myers Squibb's Oncology Revenues Will Likely Be Around $11 Billion By Next Year  Forbes

Bristol-Myers Squibb's (NYSE:BMY) oncology business accounts for over 65% of the company's valuation, according to our estimates. The segment has seen ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2G9T162